MedPath

To study the efficacy of Clomiphene Citrate and Letrozole in ovulation inductio

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: null- Women undergoing ovulation induction followed by intrauterine insemination
Registration Number
CTRI/2017/10/010003
Lead Sponsor
Kasturba Medical College Manipal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women below the age of 38 years and undergoing ovarian stimulation/induction and Intra uterine insemination(IUI) for Type II anovulatory infertility, unexplained infertility

mild male factor infertility or heterologous insemination(HI)

Exclusion Criteria

Anovulatory cycles following stimulation, tubal factor, male factor where IUI is not an option, co existing pelvic pathology like Fibroids, Endometriosis, sequelae of PID

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) The number of leading follicles and size of follicles on the day of trigger <br/ ><br>2) The day of the cycle on which the follicles where ready for trigger i.e. The size of follicles more than 18mm <br/ ><br>3) Endometrial thickness and pattern on the day of trigger <br/ ><br>4) Ovulation rate <br/ ><br>5) The relation between the doses of clomiphene citrate used 50/100 mg and follicular and endometrial responseTimepoint: On the Day 11 of the menstrual cycle follicular imaging will be done and number and size of the follicles will be assessed. <br/ ><br>The follicular imaging will be done on alternate days till leading follicle is more than 18mm. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Pregancy ratesTimepoint: Pregnancy rates will be assessed by the appearance of cardiac activity for the first time on scans done at 6 weeks after IUI.
© Copyright 2025. All Rights Reserved by MedPath